190 related articles for article (PubMed ID: 26013534)
1. [Primary CNS lymphoma. Progress in the diagnostics and therapy].
Korfel A; Schlegel U
Nervenarzt; 2015 Jun; 86(6):710-2, 714-5. PubMed ID: 26013534
[TBL] [Abstract][Full Text] [Related]
2. Primary CNS lymphoma.
Ferreri AJ; Marturano E
Best Pract Res Clin Haematol; 2012 Mar; 25(1):119-30. PubMed ID: 22409828
[TBL] [Abstract][Full Text] [Related]
3. A focus on pharmacotherapy for primary central nervous system lymphoma.
Korfel A
Expert Rev Hematol; 2015 Oct; 8(5):559-62. PubMed ID: 26159859
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
[TBL] [Abstract][Full Text] [Related]
5. Is whole-brain radiotherapy still a standard treatment for primary central nervous system lymphomas?
Schlegel U; Korfel A
Curr Opin Neurol; 2018 Dec; 31(6):733-739. PubMed ID: 30300241
[TBL] [Abstract][Full Text] [Related]
6. Have treatment protocols for primary CNS lymphoma advanced in the past 10 years.
Seidel S; Schlegel U
Expert Rev Anticancer Ther; 2019 Oct; 19(10):909-915. PubMed ID: 31594423
[No Abstract] [Full Text] [Related]
7. Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
Kim YR; Kim SH; Chang JH; Suh CO; Kim SJ; Kim Y; Hwang DY; Jang JE; Hyun SY; Cheong JW; Min YH; Kim JS
Ann Hematol; 2014 Feb; 93(2):211-9. PubMed ID: 23903866
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
9. [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].
Korfel A; Schlegel U; Schroers R
Ophthalmologe; 2015 Mar; 112(3):231-6. PubMed ID: 25721677
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and management of primary CNS lymphoma.
Roth P; Korfel A; Martus P; Weller M
Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
[TBL] [Abstract][Full Text] [Related]
12. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
Bojic M; Berghoff AS; Troch M; Agis H; Sperr WR; Widhalm G; Wöhrer A; Kalhs P; Preusser M; Rabitsch W
Eur J Haematol; 2015 Jul; 95(1):75-82. PubMed ID: 25546348
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma: biological aspects and controversies in management.
Bessell EM; Hoang-Xuan K; Ferreri AJ; Reni M
Eur J Cancer; 2007 May; 43(7):1141-52. PubMed ID: 17433666
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in primary CNS lymphoma.
Hoang-Xuan K; Camilleri-Broët S; Soussain C
Curr Opin Oncol; 2004 Nov; 16(6):601-6. PubMed ID: 15627024
[TBL] [Abstract][Full Text] [Related]
17. A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma.
Steffanoni S; Calimeri T; Anzalone N; Mastaglio S; Bernardi M; Ferreri AJ
Expert Rev Hematol; 2022 Jan; 15(1):33-43. PubMed ID: 34904506
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostics and treatment of primary vitreoretinal lymphoma].
Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
